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Uncovering the chemistry of C–C bond formation
in C-nucleoside biosynthesis: crystal structure of a
C-glycoside synthase/PRPP complex†
Sisi Gao, ‡ab Ashish Radadiya, ‡c Wenbo Li,‡d Huanting Liu,b Wen Zhu, e
Vale´rie de Cre´cy-Lagard, f Nigel G. J. Richards *cg and
James H. Naismith *dh
The enzyme ForT catalyzes C–C bond formation between
50-phosphoribosyl-10-pyrophosphate (PRPP) and 4-amino-1H-
pyrazole-3,5-dicarboxylate to make a key intermediate in the
biosynthesis of formycin A 50-phosphate by Streptomyces kanihar-
aensis. We report the 2.5 Å resolution structure of the ForT/PRPP
complex and locate active site residues critical for PRPP recogni-
tion and catalysis.
There is renewed interest in the synthesis and characterization
of C-nucleosides1 driven by the potency of GS-5734 against
ebola,2 and coronaviruses, including those that cause SARS3
and MERS.4 In C-nucleosides, the nucleobase is connected to
C-10 of the sugar ring by a C–C bond rather than a C–N bond,
thereby improving hydrolytic stability and altering its stereo-
electronic properties.5,6 With the exception of pseudouridine
synthase,7,8 relatively little is known about the structures and
catalytic mechanisms of enzymes that form C-ribosides and
C-glycosides.9,10 Recent work identifying the biosynthetic gene
clusters for formycin A 1,11–13 pyrazomycin 2 (also known as
pyrazofurin)14,15 and showdomycin 316 (Fig. 1a) has laid the
foundation for obtaining an enhanced understanding of two
new enzymes (ForT and PyfQ), both of which catalyse C–C
bond-forming steps in C-nucleotide biosynthesis. The function
of ForT and PyfQ was originally assigned based on their
homology to the enzyme (4-(b-D-ribofuranosyl)hydroxybenzene)
(RHP) synthase, which mediates a key step in methanopterin
biosynthesis.17–20 These enzymes all utilize 50-phosphoribosyl-10-
pyrophosphate (PRPP) and an aromatic carboxylic acid to make
the new C–C bond (Fig. 1b). The liberation of inorganic pyro-
phosphate and irreversible CO2 release provide the driving force
for these reactions. Sequence alignments show that these three
enzymes are homologous with, and therefore evolutionarily
related to, homoserine kinase,21 a member of the GHMP kinase
superfamily (Fig. S1, ESI†).22
Two previous studies12,14 have shown that the substrate of
ForT is 4-amino-1H-pyrazole-3,5-dicarboxylate (ADPA) 5 (Fig. 1b)
and that the enzyme-catalyzed reaction yields C-nucleotide 6
(Fig. 1b), an intermediate in formycin biosynthesis. Nothing was
reported, however, concerning the structure of ForT or the active
site residues that play a role in substrate binding and/or catalysis.
Fig. 1 (a) Formycin A 1, pyrazomycin 2 and showdomycin 3. (b) A new
class of C–C bond forming enzymes that utilise 50-phosphoribosyl-10-
pyrophosphate 4 and aromatic carboxylic acids to make C-nucleotides.
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We therefore overexpressed and purified recombinant, wild type
(WT) ForT in Escherichia coli, and grew crystals of the enzyme in
the presence of 10 mM PRPP 4. The resulting crystals were soaked
in 200 mM of PRPP 4 before data collection at the Diamond Light
Source, allowing us to solve the structure of the ForT/PRPP
complex to 2.5 Å resolution (Fig. 2a and Table S1, ESI†).§ The
crystal asymmetric unit contains a ForT monomer with residues
11–171, 180–205 and 209–341 (C-terminus) experimentally located
in electron density; we assume that missing residues are located
in conformationally disordered regions. The ForT monomer has
three antiparallel b-sheets which form the core of the structure.
Two of the sheets share the same elongated strand (residues 11 to
17 for sheet 1; 18 to 24 for sheet 2) and sit end to end (Fig. 2a). The
third sheet sits opposite, and partially stacks against, sheet 2.
There are two a-helices packed against one face of sheet 1 with
a third packing against the other two. Sheet 2 has a very small
a-helix packed against one of its faces whilst sheet 3 has two
helices attached. A bundle of four helices is packed against the
ends of sheet 2 and sheet 3. Gel filtration and multi-angle light
scattering suggests the enzyme to be a dimer in solution (Fig. S2,
ESI†), and the 2-fold rotation axis in the crystal does result in one
(and only one) plausible dimer that relies on contacts between the
helical bundles of each monomer (Fig. 2b). Interestingly, analysis
of this dimeric arrangement with the PISA server23 assigns the
dimer with low confidence (0.3 on a 0 to 1 scale) due to relatively
few interactions between the monomers and the limited amount
of buried surface area.
The sequence of ForT is distantly related to homoserine
kinase (o20% identity), a member of the GHMP kinase
superfamily, although there are regions of strong sequence
conservation. The ForT structure reveals that the closest
structural analogue is indeed homoserine kinase from
Methanocaldococcus jannaschii (1fwl)21 (root mean square devia-
tion (rmsd) of 2.6 Å over 266 Ca atoms). Superposition reveals
the conservation of the three antiparallel b-sheets and the
helices (Fig. S3a, ESI†). There is a notable difference between
the structures centred on the bundle of four helices, ForT has
two longer loops (residues 25 to 35 and residues 157 to 181).
Homoserine kinase is a dimer and like ForT, the dimer inter-
face uses the same bundle of helices. However, the longer loops
in ForT preclude exactly the same dimeric arrangement seen for
homoserine kinase; the second monomer in the ForT dimer is
rotated by approximately 601 relative to second monomer in the
homoserine kinase dimer (Fig. S3b, ESI†). ForT is also structu-
rally related to mevalonate kinase24 (PDB 6mde; rmsd 2.6 Å
over 262 Ca atoms). The mevalonate kinase has a completely
different dimeric arrangement, however, even though it too
uses the same helical bundle to form the dimer (Fig. S3c, ESI†).
The difference electron density map indicated the presence
of bound PRPP in the enzyme (Fig. S3d, ESI†). Pyrophosphate
and phosphate only were therefore added to the model and the
structure further refined. The resulting difference density con-
necting the phosphate and pyrophosphate moieties improved
allowing fitting of the ribose ring, thereby locating PRPP in the
ForT/PRPP complex (Fig. 2c). PRPP is located in the centre of
the monomer, remote from the dimer interface (Fig. 2b and d).
The 50-phosphate of PRPP sits in a pocket and forms salt
bridges with the side chains of Arg-19 and Arg-135; it also
interacts with the N-terminus of short helix in the helical
bundle. Hydrogen bonds are also observed between the
50-phosphate and the side chains of Thr-106, Ser-139, Ser-142
and the backbone NH of Ser-142 (Fig. 2d). The pyrophosphate
moiety sits in different pocket and also makes a salt bridge with
Arg-19. The pyrophosphate is hydrogen bonded to all seven
backbone amides in a tight turn comprising residues His-99 to
Ser-104 as well as with the side chain of His-99 and two water
molecules (Fig. 2d). This (pyro)phosphate binding tight turn is
a conserved feature of the GHMP kinases (Fig. 2d and Fig. S1,
ESI†). A bound water also appears to bridge the phosphate and
pyrophosphate moieties. Our assignment relies on the observed
coordination sphere being consistent with water and not of a
magnesium ion. The ribose ring only makes one van der Waals
contact with the side chain of Val-294. The weaker density of
the ribose also suggests some conformational flexibility. We
note that two disordered loops (172 to 179 and 210 to 340) are
plausibly within reach of this region and it is thus possible
additional protein/ribose interactions may exist. A model of the
PRPP complex of RFA-P synthase, another member of this class
of C–C bond-forming enzymes (Fig. 1b) and homologous
to ForT, has been reported.20 In the model, R26 of RFA-P
synthase,20 was identified to be adjacent to PRPP and impor-
tant for binding the second substrate. The equivalent residue,
(R33) in our ForT/PRPP complex is around 18 Å distant from
PRPP with intervening secondary structure, thus any role in
catalysis would require significant structural re-arrangement.
Fig. 2 X-Ray crystal structure of the WT ForT/PRPP complex. (a) The ForT
monomer shown as a cyan cartoon, PRPP, shown in sticks (carbon yellow,
phosphorous orange, oxygen red) is at the centre of the monomer. (b) The
ForT dimer is generated by crystal symmetry, the second monomer is pale
pink cartoon, PRPP is remote from the dimer interface. (c) The final 2Fo–Fc
map contoured at 1.2s for PRPP (shown as in Fig. 2a) (the original Fo–Fc
map is shown in Fig. S3, ESI†). (d) PRPP is bound to the enzyme by an
extensive array of hydrogen bonds. The loop (Gln-98 to Ser-108), char-
acteristic of GHMP kinase superfamily, plays a crucial role in substrate
binding. Protein carbon atoms are coloured in cyan, nitrogen in blue, other
atoms as in Fig. 2a.
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It therefore appears that the model20 and our crystal structure
differ significantly in their placement of PRPP.
Using isothermal titration calorimetry (ITC) the dissociation
constant of the ForT/PRPP complex was determined to be
4.0 mM (Table S2, ESI†). We did not observe any binding
of ribose 5-phosphate. Informed by the crystal structure, we
prepared a series of site-specific ForT variants by mutagenesis
(Table S3, ESI†) and used these variants in ITC measurements
(Fig. S4a, ESI†), which confirmed that Arg-19, Thr-106 and
Arg-135 are indeed essential for PRPP binding (Table S2, ESI†).
Replacing Gly-134 by proline decreased PRPP binding by almost
100-fold, consistent with the idea that the conformation of this
loop segment is important in recognition.
With the crystal structure in hand, standard modeling
methods were used to construct the disordered loops in ForT
(ESI†)25 The active site has to accommodate the atoms of both
PRPP 4 and the reaction product 6 during catalytic turnover.
Making the reasonable assumption that C–C bond formation
takes place on the opposite face of the ribose ring to that of the
pyrophosphate moiety, we constructed molecular probes 7 and
8 (Fig. 3a and b). The probes represent molecular ‘‘hybrids’’ of
PRPP 4 and product 6 and when docked into the PRPP complex
crystal structure, the rotamers around the C–C bond (high-
lighted red in Fig. 3) helped explore the active site. These
qualitative studies revealed a large positively charged pocket
lined by several polar residues (Fig. 3c and d), which would be
well suited to accommodate the negatively charged ADPA
substrate 5. These models also suggest that the protein likely
undergoes some conformational rearrangement to accommo-
date both substrates within the active site (Fig. S3e, ESI†).
We also evaluated the catalytic activity of the recombinant
WT ForT used to obtain the X-ray crystal structure. Thus, LCMS
confirmed formation of the expected product12 when the
enzyme was incubated with PRPP 4 and ADPA 5, analysis with
LCMS confirmed the production of the expected product12
(Fig. S4b, ESI†). The activity of WT ForT and a number of ForT
variants were also assayed using membrane-inlet mass spectro-
metry (MIMS)26–28 to measure ForT-catalyzed CO2 production
(Table S2 and Fig. S4c, ESI†). These experiments showed that
WT ForT has a specific activity of 0.002 U mg1 under
the reaction conditions used to identify the substrates for the
ForT-catalysed reaction by Liu and co-workers.12 The addition
of EDTA to the reaction mixture abolished activity, suggesting
that Mg2+ is needed for catalytic activity. The ease of the MIMS-
based assay also permitted a preliminary kinetic assessment of
selected ForT variants (Table S2, ESI†). Unfortunately, many of
these ForT variants exhibited poor stability under our standard
reaction conditions.
It is perhaps surprising that ForT should share structural
homology with kinases because phosphorylation and C-nucleoside
bond formation are very different chemical transformations.
Superposition of the ForT/PRPP complex with that of homoserine
kinase bound to phosphoaminophosphonic acid-adenylate ester
(AMP-PNP) (PDB 1h72),29 however, shows that the g-phosphate of
ATP overlaps with the C-10 phosphate of the pyrophosphate
(proximal phosphate) of PRPP (Fig. 4a). Similarly, superposing
the ForT/PRPP complex with homoserine kinase bound to ADP
(PDB 1fwk)21 shows that the b-phosphate of ADP overlaps with
the distal phosphate of the pyrophosphate in PRPP (Fig. S3f,
ESI†). We have previously noted that structural and chemical
similarity between an adenylating enzyme and a (non-GHMP
superfamily) kinase arose from the shared need to stabilize a
negatively charged phosphate transition state.30 In GHMP
kinases, the g-phosphate undergoes nucleophilic attack and the
enzyme, using the GHMP kinase loop and a Mg2+ ion,21 stabilizes
the developing negative charge (Fig. 4b). Both the g-phosphate in
homoserine kinase and the proximal phosphate of PRRP in ForT
make very similar interactions with the GHMP kinase loop in
their respective structures. This degree of conservation we take
to imply that in both enzymes, stabilization of the negatively
Fig. 3 Location of the second substrate (a and b) probes 7 and 8 used in
model building studies. Several rotamers about the C-10–C-4 bond (red)
were considered. (c) PRPP sits in a large positively charged pocket that
could also bind the negatively charged ADPA molecule. The binding
pocket is shown as an electrostatic surface. (d) The active site pocket is
lined by several polar residues, coloured as in Fig. 2d.
Fig. 4 (a) Overlay of PRPP in the ForT/PRPP complex with AMP-PNP
homoserine kinase complex. The proximal pyrophosphate of PRPP
overlaps with the g-phosphate of AMP-PNP. (b) The transition state for
g-phosphoryl transfer in the reaction catalysed by homoserine kinase.
(c) Proposed mechanism for ForT-catalysed C–C bond formation. Note
that the configuration of the correct epimer at the new stereogenic centre
remains to be established.
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charged phosphate is key. In ForT, this need for stabilization
implies that the C-10–pyrophosphate bond undergoes signifi-
cant dissociation in the rate determining step forming an
SN1-like transition state with an oxocarbenium ion (Fig. 4c). The
breakage of the pyrophosphate ribose bond would permit the
movement of the ribose ring which we noted earlier, is required
for formation of the adduct with ADPA. The oxocarbenium ion
would be highly reactive to the electron rich aromatic ADPA
molecule and the subsequent elimination of CO2 would act as
an irreversible step. Based on the similarity to homoserine kinase,
we presume the apparent requirement for Mg2+ arises from
stabilisation of pyrophosphate.
C-Nucleosides, such as formycin, are promising medicines
for the treatment of viral diseases. Understanding their bio-
synthesis lays a firm foundation for identifying new biocatalytic
approaches to novel anti-viral agents.31 The work reported here,
which continues our ongoing effort to obtain structures for all
of the enzymes involved in formycin biosynthesis,32 represents
a significant advance by identifying key residues that mediate
substrate binding and catalysis, setting the scene for determining
detailed functional studies and reengineering efforts. In addition,
these findings provide new insights into the different ways enzymes
can bind and utilize the high energy PRPP molecule.33,34
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